Patients presenting with posterior uveitis in the context of ocular toxoplasmosis who also carry a sulfa allergy represent a specific clinical subgroup — one in which the choice of antimicrobial therapy must be carefully adapted to avoid allergic reactions.
The patient has posterior uveitis attributable to ocular toxoplasmosis and a documented sulfa allergy. This combination requires selecting agents that are appropriate for sulfa-allergic patients rather than defaulting to the standard sulfa-based approach.
Management involves specific antibiotic alternatives suitable for patients who cannot receive sulfa-based therapy, used together with systemic agents that address inflammation and support tolerability. The full regimen — including the complete selection of agents and supporting measures — is available in the structured protocol.
DOI: 10.4103/0301-4738.58470
In patients with sulfa allergy, clindamycin and azithromycin are suitable alternatives.
View source ↗